Vident Investment Advisory’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-17,849
| Closed | -$133K | – | 842 |
|
|
2023
Q2 | $133K | Buy |
17,849
+1,716
| +11% | +$12.8K | ﹤0.01% | 1108 |
|
|
2023
Q1 | $108K | Buy |
16,133
+2,552
| +19% | +$17K | ﹤0.01% | 1165 |
|
|
2022
Q4 | $105K | Buy |
13,581
+1,934
| +17% | +$14.9K | ﹤0.01% | 1104 |
|
|
2022
Q3 | $124K | Buy |
11,647
+1,166
| +11% | +$12.4K | ﹤0.01% | 1047 |
|
|
2022
Q2 | $85K | Buy |
+10,481
| New | +$85K | ﹤0.01% | 1210 |
|